← All Conditions ← Cardiovascular Overview

Pernicious Anemia

★ CMTO Exam Focus

Pernicious anemia is a specific type of megaloblastic anemia caused by autoimmune destruction of the gastric parietal cells or their product, intrinsic factor — a glycoprotein essential for vitamin B12 absorption in the terminal ileum. Without intrinsic factor, dietary B12 cannot be absorbed regardless of intake, leading to deficiency that causes both hematologic dysfunction (macrocytic anemia) and progressive neurological damage (demyelination of the posterior and lateral columns of the spinal cord). The neurological damage can become irreversible if treatment is delayed, making early recognition critical.

Recognition

  • Hematologic signs: Profound fatigue, pallor, tachycardia, dyspnea on exertion — typical of severe anemia. Jaundice (from ineffective erythropoiesis and intramedullary hemolysis). Glossitis (smooth, sore, "beefy red" tongue).
  • Neurological signs (the critical differentiator from other anemias): Symmetric paresthesias of the hands and feet (earliest neurological finding). Loss of vibratory sense and proprioception (posterior column demyelination). Progressive spastic ataxia — unsteady, wide-based gait with positive Romberg sign. Cognitive changes (confusion, memory loss, depression, even dementia) that may precede detectable blood changes — a dangerous diagnostic trap.
  • Key pathophysiology: B12 is essential for two critical biochemical processes: (1) DNA synthesis in rapidly dividing cells (erythroid precursors, GI mucosa) — deficiency causes macrocytosis (MCV > 100 fL, large, fragile RBCs). (2) myelin protein methylation — deficiency causes progressive demyelination of the spinal cord (subacute combined degeneration), starting with the posterior columns (proprioception, vibration) and extending to the lateral corticospinal tracts (motor — spasticity, hyperreflexia).
  • Not a dietary deficiency: Pernicious anemia is an absorption failure from autoimmune destruction of intrinsic factor, not inadequate intake. Other causes of B12 malabsorption include gastrectomy, ileal resection, Crohn's disease, and chronic PPI use.
  • Diagnosis: Elevated MCV (> 100 fL), low serum B12, elevated methylmalonic acid and homocysteine, and positive anti-intrinsic factor antibodies or anti-parietal cell antibodies.

MT Relevance

  • Peripheral neuropathy governs pressure decisions: Impaired sensation in the extremities means the client cannot provide accurate feedback about pressure, temperature, or pain. Use conservative pressure in areas with paresthesia or reduced sensation. Always test hydrotherapy temperature on areas of intact sensation before applying to numb areas.
  • Proprioceptive loss creates fall risk: Clients with advanced pernicious anemia may have an unsteady gait and poor balance (positive Romberg). Assist with getting on and off the table. Ensure clear pathways and adequate lighting.
  • Fatigue management: Shorter sessions may be better tolerated. Allow extra transition time.
  • Cognitive changes: Confusion or memory impairment may affect the client's ability to report symptoms accurately during treatment. Be alert to nonverbal signs of discomfort.
  • Broad soothing effleurage is appropriate for numb areas — provides sensory input without deep manipulation that the client cannot accurately feel.

Required Actions

  • New-onset symmetric paresthesias with fatigue and pallor: Refer for B12 level and CBC — early detection prevents irreversible neurological damage
  • Progressive gait unsteadiness or cognitive decline in a client with known pernicious anemia — medical referral for treatment adequacy reassessment
  • Temperature-test all hydrotherapy applications on areas of intact sensation before applying to numb areas

Key Takeaways

  • Pernicious anemia results from autoimmune destruction of intrinsic factor, preventing B12 absorption — it is a failure of absorption, not dietary deficiency
  • Untreated B12 deficiency causes irreversible demyelination of the spinal cord (subacute combined degeneration), leading to permanent nerve damage, spastic ataxia, and potentially paralysis
  • Neuropsychiatric symptoms (confusion, memory loss, depression) may precede detectable blood changes — a diagnostic trap
  • Deep or intrusive techniques are contraindicated in areas of impaired sensation because the client cannot provide accurate pain feedback
  • Proprioceptive loss creates fall risk — assist with table transfers and ensure safe movement in the clinic
  • Temperature-test hydrotherapy on intact-sensation areas before applying to numb areas to prevent burns

Sources

  • Rattray, F., & Ludwig, L. (2000). Clinical massage therapy: Understanding, assessing and treating over 70 conditions. Talus Incorporated.
  • Werner, R. (2012). A massage therapist's guide to pathology (5th ed.). Lippincott Williams & Wilkins.
  • Porth, C. M. (2014). Essentials of pathophysiology: Concepts of altered states (4th ed.). Lippincott Williams & Wilkins.
  • Tortora, G. J., & Derrickson, B. H. (2021). Principles of anatomy and physiology (16th ed.). Wiley.